Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT07469813Not ApplicableCompleted

Non-Surgical Periodontal Treatment With an Oscillating Ultrasonic Device With Adjunctive Root Polishing. A Randomized, Comparative, Prospective Clinical Trial.

Role: lead

NCT07299838Completed

Palopegteriparatide in Chronic Hypoparathyroidism

Role: collaborator

NCT07094568Recruiting

Tirzepatide vs Liraglutide in Bone

Role: collaborator

NCT07160348Not Yet Recruiting

Translation and Validation of the Hypoparathyroidism Patient Experience Scales (HPES) Questionnaire in Greek

Role: collaborator

NCT07117097Not ApplicableNot Yet Recruiting

Minimally Invasive Non- Surgical Periodontal Therapy of Intrabony Defects: Healing Patterns and Smoking Impact

Role: collaborator

NCT05643287Not ApplicableNot Yet Recruiting

The Effect of Time on the Outcome of Periodontal Treatment.

Role: lead

NCT04338529Completed

Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation

Role: lead

NCT04203212Completed

BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH

Role: collaborator

NCT04695587Unknown

The Role of Sympathetic Tone Regarding the Anatomical and Functional Recovery of the Left Ventricle in TakoTsubo Syndrome

Role: collaborator

NCT04681612Unknown

The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA

Role: collaborator

NCT02499237Phase 4Completed

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation

Role: collaborator

NCT02472782Completed

Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication

Role: lead

NCT01572545Not ApplicableCompleted

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

Role: collaborator

All 13 trials loaded